MMP9 and early-onset autosomal dominant Alzheimer disease: Among these enzymes, abnormal expressions or activations of gelatinases, MMP-2 (gelatinase A) and MMP-9 (gelatinase B), were reported to be associated with numerous disease conditions, such as cancer, cardiovascular diseases and Alzheimer's disease [40–42].